# LYVISPAH

NDC: 64896-078
Generic name: baclofen
Labeler / Manufacturer: Amneal Pharmaceuticals LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: GRANULE
Routes: ORAL
Marketing started: 20230601

FDA application: NDA215422

## Active ingredients

- BACLOFEN: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"64896-078"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=64896-078
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f8992a56-9010-4c4b-84d5-ddcc3e2c3317